GENERIC NAME OF THE MEDICINAL PRODUCT:
B. Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets (50mg+20mg)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film coated modified release tablet contains:
Metoprolol Succinate IP (23.75mg)
Equivalent to Metoprolol Tartrate…………25mg
(As extended release form)
Olmesartan Medoxomil IP……………………20mg
Colour: Ponceau 4R Lake & Titanium Dioxide IP
B) Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets (50mg+20mg)
Each film coated modified release tablet contains:
Metoprolol Succinate IP (47.5mg)
Equivalent to Metoprolol Tartrate…………50mg
(As extended release form)
Olmesartan Medoxomil IP……………………20mg
Colour: Quinoline Yellow WS
THERAPEUTIC INDICATIONS:
CAUTION & SCHEDULE:
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Tablet to be swallowed as a whole, and not to be chewed or crushed.
SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
STORAGE & DOSAGE:
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician.
Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets 25mg+20mg Technical Specification:
| Product Name: | Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets |
| Brand Name: | Generic |
| Strength: | (25mg+20mg), (50mg+20mg) |
| Dosage Form: | Tablets (Film coated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10 Blister strips of 10 Tablets Each |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antihypertensive |
| Indication: | Olmesartan Medoxomil + Metoprolol Succinate is used in the treatment of Hypertension (high blood pressure). Olmesartan Medoxomil + Metoprolol Succinate is a combination of two blood-pressure lowering medicines: Olmesartan Medoxomil and Metoprolol Succinate. Olmesartan Medoxomil is an angiotensin receptor blocker (ARB). |
| Storage: | Store at temperature not exceeding 30℃. Store in cool, dry & dark place. Protect from Light & moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets (25mg+20mg)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets (25mg+20mg)
Each film coated modified release tablet contains:
Metoprolol Succinate IP (23.75mg)
Equivalent to Metoprolol Tartrate…………25mg
(As extended release form)
Olmesartan Medoxomil IP……………………20mg
Colour: Ponceau 4R Lake & Titanium Dioxide IP
THERAPEUTIC INDICATIONS:
Olmesartan Medoxomil + Metoprolol Succinate is used in the treatment of Hypertension (high blood pressure). Olmesartan Medoxomil + Metoprolol Succinate is a combination of two blood-pressure lowering medicines: Olmesartan Medoxomil and Metoprolol Succinate. Olmesartan Medoxomil is an angiotensin receptor blocker (ARB).
CAUTION & SCHEDULE:
CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablet to be swallowed as a whole, and not to be chewed or crushed.
SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
STORAGE & DOSAGE:
Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician.
Introduction to Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets 25mg+20mg
What is this Combination?
This FDC is developed for patients requiring dual antihypertensive therapy. The 25mg (ER) + 20mg strength is particularly preferred for:
-
Mild to moderate hypertension
-
Newly diagnosed hypertensive patients
-
Combination therapy initiated at lower beta-blocker doses
-
Patients needing long-term 24-hour blood pressure control
The extended-release feature ensures steady plasma concentration, improving adherence and minimizing side effects.
Why Global Demand is Increasing
Hypertension affects 1.3 billion people worldwide, and the demand for high-quality FDCs is rapidly growing—particularly in Africa, Southeast Asia, CIS countries, and LATAM markets.
Governments and private procurement agencies rely heavily on Indian WHO-GMP manufacturers, with Taj Pharma being among the top suppliers for antihypertensive medications.
In-Depth Manufacturing & Export Details for Importers, Distributors & Buyers
Taj Pharma provides complete support, making it the most trusted source for Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets 25mg+20mg export from India.
Regulatory Documentation Provided
Global buyers receive a complete regulatory package, including:
-
WHO-GMP Certificate
-
EU-GMP Compliance Support
-
Certificate of Pharmaceutical Product (COPP)
-
COA (Certificate of Analysis)
-
BMR/BPR
-
CTD / ACTD Dossier
-
Stability Data – Zone I–IV
-
MSDS & MOA
-
Manufacturing License
-
Free Sale Certificate
-
Testing Procedures & Validation Reports
This ensures smooth product registration in:
-
Ministry of Health portals
-
Government tenders
-
Institutional supply chains
-
Private brand registrations
Custom Packaging & Labeling Options
Taj Pharma offers flexible packaging options for buyers, including:
Primary Packaging:
-
Alu-Alu blister
-
PVC blister
-
HDPE bottles
-
Bulk packs for B2B supply
Secondary Packaging:
-
Export cartons
-
Multi-language printed boxes (Arabic / French / Spanish / Swahili / Russian)
-
Custom branding for OEM / Third-party manufacturing
Why Buyers Prefer Taj Pharma Packaging:
-
Moisture-protected
-
International shipping-grade cartons
-
Barcoding & serialization available
-
Private labeling rights
Shelf-Life, Storage, Dosage Form
-
Shelf Life: 24–36 months
-
Storage: Store below 25°C, protect from moisture
-
Dosage Form: Extended-release film-coated tablets
-
Pharmacopoeia: IP / USP / EP (as required)
Export Certifications
Taj Pharma holds prestigious international certifications:
-
WHO-GMP
-
ISO 9001:2015
-
ISO 14001
-
GLP Certified Laboratories
-
OHSAS 18001
This makes Taj Pharma a preferred global exporter of antihypertensive medicines.
Target Countries & Export Markets
Taj Pharma exports Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets 25mg+20mg to more than 80 countries.
Key markets include:
-
GCC (UAE, Oman, Saudi Arabia, Kuwait, Qatar)
-
Africa (Nigeria, Kenya, Ghana, Ethiopia, Tanzania, Uganda)
-
South Asia (Sri Lanka, Nepal, Myanmar, Afghanistan)
-
CIS (Belarus, Kazakhstan, Tajikistan)
-
LATAM (Bolivia, Peru, Guatemala)
-
Eastern Europe
-
Caribbean markets
These countries recognize Taj Pharma for its quality, affordability, and consistent supply chain.
Why Taj Pharma is the Most Trusted Manufacturer, Supplier & Exporter
1. Cutting-Edge WHO-GMP Manufacturing Facilities
Taj Pharma’s manufacturing plant in Vapi, Gujarat is equipped with:
-
High-precision granulation, compression & coating systems
-
Zero-contamination cleanrooms
-
Automated blister/packing lines
-
In-house R&D and stability chambers
-
Digitally monitored QA/QC systems
Every batch undergoes more than 40 quality tests, ensuring consistent global standards.
2. Affordable Pricing with International Quality
Taj Pharma offers:
-
Competitive bulk pricing
-
Complete transparency in production
-
International pharmacopoeia compliance
This makes Taj Pharma the top choice for Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets 25mg+20mg Supplier in India.
3. Strong Global Supply Chain & Logistics
Buyers benefit from:
-
24–72 hour dispatch readiness
-
Sea/Air freight expertise
-
Temperature-controlled warehousing
-
Dedicated export managers
Taj Pharma ensures timely deliveries even to remote markets.
4. Top 20 Countries
USA, UK, South Africa, Kenya, Nigeria, Ghana, Vietnam, Myanmar, Philippines, Bangladesh, Sri Lanka, Iraq, Yemen, Uzbekistan, Kazakhstan, Georgia, Peru, Bolivia, Ukraine, Cambodia
Technical Product Specification Table
| Parameter | Details |
|---|---|
| Product Name | Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets |
| Strength | 25mg (ER) + 20mg |
| Dosage Form | Extended Release Film-Coated Tablet |
| Packing | Alu-Alu / Blister / HDPE Bottle / Bulk |
| Shelf Life | 24–36 months |
| Certification | WHO-GMP, ISO, COPP |
| Pharmacopoeia | IP/USP/EP |
| Storage | Store below 25°C; keep dry |
| Manufacturer | Taj Pharma India Ltd., Vapi, Gujarat |
Call to Action
If you are a distributor, importer, PCD franchise owner, hospital buyer, or tender authority, Taj Pharma is your most reliable partner for high-quality Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets 25mg+20mg.
Contact Taj Pharma India Ltd.:
📧 Email: info@tajpharma.com
🌐 Website: www.tajpharma.com
📍 Vapi, Gujarat – India
Get the best price, fastest shipping, and complete regulatory support.
Top 20 FAQs
1. What are these tablets used for?
They treat hypertension and prevent cardiac complications.
2. Is 25mg+20mg a starting dose?
Yes, this lower combination dose is often recommended for initial therapy.
3. Who is the leading manufacturer in India?
Taj Pharma is the top WHO-GMP certified manufacturer.
4. Are these tablets safe for long-term use?
Yes, under medical supervision.
5. What are the common side effects?
Dizziness, headache, nausea, weakness, slow heart rate.
6. Is dizziness normal after taking this medicine?
Yes; patients should get up slowly from sitting/lying positions.
7. Is private labeling available?
Yes, Taj Pharma offers OEM/contract manufacturing globally.
8. What packaging types are available?
Alu-Alu, blister, HDPE bottle, and export bulk.
9. Is CTD dossier available for registration?
Yes, full CTD/ACTD dossiers are provided.
10. Can Taj Pharma supply to government tenders?
Yes, Taj Pharma is a preferred tender-listed manufacturer.
11. What certifications does the facility have?
WHO-GMP, ISO, GLP, COPP, and more.
12. Are free samples available?
Yes, for qualified distributors/agents.
13. What is the product’s shelf life?
24–36 months.
14. Do you support multi-language packaging?
Yes, Arabic, French, Swahili, Spanish, Russian, etc.
15. What is the lead time for exports?
Typically 2–3 weeks.
16. Does the product comply with USP/EP?
Yes, upon buyer requirement.
17. Can these tablets be crushed?
No—ER tablets must be swallowed whole.
18. Are stability studies included?
Yes, zone-wise stability data is available.
19. Do you assist with product registration?
Yes, full regulatory assistance is provided.
20. How do I get a quotation?
Email Taj Pharma at info@tajpharma.com






